[blindza] Fw: The 'Holy Grail' of Ophthalmic Devices
- From: "Jacob Kruger" <jacobk@xxxxxxxxxxxxxx>
- To: "BlindZA" <blindza@xxxxxxxxxxxxx>
- Date: Sun, 23 Aug 2009 09:54:14 +0200
The 'Holy Grail' of Ophthalmic Devices.
By Austin Weber, August 20, 2009.
Doctors and engineers have developed a wide variety of implantable lenses
that
improve eyesight. But, the ultimate ophthalmic device is an artificial
retina.
Believe it or not, the bionic eye is more fact than fiction.
A device called Argus II is currently being developed by engineers at five
U.S.
Department of Energy laboratories and four universities. A private company,
Second Sight Medial Products Inc., is marketing the bionic eye. The
high-density
microelectronic-tissue hybrid device aims to restore sight to people blinded
by
diseases such as age-related macular degeneration (AMD) and retinitis
pigmentosa
(RP).
People with AMD and RP are blind because retinal photoreceptors called rods
and
cones degenerate and lose function. According to Mark Humayun, M.D., an
ophthalmologist at the Doheny Eye Institute at the University of Southern
California, rods and cons are cells that capture light and transmit it into
electrical signals. The signals are passed through underlying retinal cells
and
down the optic nerve to the brain, where visual images are formed.
The U.S. Department of Energy has spent $63 million on the artificial retina
project since 2001. Funding is scheduled to end in 2010. The goal of the
program
is to replace the lost light-gathering rods and cones with a video camera
and to
use the information captured by the camera to electrically stimulate the
part of
the retina not destroyed by disease.
“Argus II is a three-part system designed to transmit information about the
physical environment directly to an individual’s retina, thus bypassing the
photoreceptors that have been damaged,” says Humayun. It consists of an
array of
60 electrodes that are surgically implanted and attached to the retina.
“The electrodes conduct information acquired from an external camera mounted
on
a pair of eyeglasses,” Humayun points out. A battery pack worn on a belt
powers
the system. “The implant has been designed to last many years, but can be
safely
removed if necessary,” explains Humayun.
The metal traces forming the electrodes are less than 10 micrometer thick.
The
electrode array is embedded in a soft biocompatible polymer to allow it to
conform to the curvature of the retina.
Stimulation is done with a thin, flexible metal electrode array that has
been
patterned on soft plastic material similar to a contact lens. The delicate,
electrical stimulation of the retina needs to be performed in the eye’s
saltwater environment without shorting out any electronic components.
Another
challenge engineers face is finding a bioadhesive that can be used to attach
the
microelectrode array to the surface of the retina.
Engineers at Lawrence Livermore National Laboratory are addressing those
challenges and developing an advanced ocular surgical tool that allows
ophthalmologists to implant microelectrode arrays with minimal tissue
damage.
The 60-electrode Argus II device has already been implanted in 29 patients
around the world. A newer, higher resolution model will be available within
the
next few years. The third-generation device will feature more than 200
electrodes. However, the long-term goal of the research project is to
develop a
bionic eye equipped with more than 1,000 electrodes, which would allow
facial
recognition.
Because that density is beyond conventional packaging technology, it creates
a
wide variety of engineering challenges. For instance, the compact size of
the
artificial retina’s electronics package makes it difficult to mechanically
and
electrically interconnect the microelectronics inside.
Researchers at Sandia National Laboratories are developing state-of-the-art
packaging technology to assemble and integrate the microelectronic
components
with the thin-film electrode array. Biocompatibility issues are driving much
of
this effort, requiring the high-density interconnects to be insulated with a
nonconductive film to prevent moisture and ionic and biological
contamination
from causing device failure.
The artificial retina’s custom-designed integrated circuit (IC) is the
system’s
brain. Its job is to take signals from the external camera and convert them
into
stimuli that are transferred to the electrode array. The IC performs this
function via a series of interconnected, nanosize nodes.
“The current method for achieving higher electrode currents involves
assembly
with a lot of bond wires and other interconnects,” says Sean Pearson, an IC
design engineer at Sandia. “This makes the device tedious to build and very
difficult to yield full functionality.”
Pearson and his colleagues are developing a dual-sided IC to simplify how
data
are routed and to better integrate the electronics package with the
electrode
array. “We’re using one side to bring the signals in and the other side to
put
them out,” Pearson points out.
For the electronics substrate, the engineers are using a Sandia-patented
MEMS
technique to selectively etch away parts of the silicon chip or add new
structural layers to create tiny features that cannot be made any other way.
This micromachining process allows wiring of the electrical connections
through
the chip for access to both sides.
“By using that bottom surface, which adds interconnect space instead of
eliminating it, we’re able to get higher interconnect densities,” thereby
allowing the number of electrodes on the array to be increased without
making
the device bigger, says Murat Okandan, a microsystems engineer at Sandia.
Austin Weber
webera@xxxxxxxxxxxx
Senior Editor
Source URL:
http://www.assemblymag.com/Articles/Web_Exclusive/BNP_GUID_9-5-2006_A_10000000000000645
__________ Information from ESET NOD32 Antivirus, version of virus signature
database 4359 (20090822) __________
The message was checked by ESET NOD32 Antivirus.
http://www.eset.com
----------
To send a message to the list, send any message to blindza@xxxxxxxxxxxxx
----------
To unsubscribe from this list, send a message to blindza-request@xxxxxxxxxxxxx
with 'unsubscribe' in the subject line
---
The 'homepage' for this list is at http://www.blindza.co.za
Other related posts:
- » [blindza] Fw: The 'Holy Grail' of Ophthalmic Devices - Jacob Kruger